{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:40:35Z","timestamp":1777905635609,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001445","name":"Alex&apos;s Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008680","name":"Universidad de Puerto Rico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008680","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022985","name":"The American Legion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022985","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100025821","name":"American Legion Auxiliary","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025821","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bneo.2025.100135","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:32:49Z","timestamp":1751430769000},"page":"100135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Juvenile myelomonocytic leukemia stem cells are sensitive to NK cell\u2013mediated lysis and express targetable antigens"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5089-7150","authenticated-orcid":false,"given":"Shannalee","family":"Martinez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir V.","family":"Senyukov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suheyla","family":"Hasgur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianexys","family":"Aquino-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Emanuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. Lucy","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-4623","authenticated-orcid":false,"given":"Elliot","family":"Stieglitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9493-3607","authenticated-orcid":false,"given":"Gregory","family":"Behbehani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0359-3900","authenticated-orcid":false,"given":"Amanda R.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6693-5392","authenticated-orcid":false,"given":"Dean A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bneo.2025.100135_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood.V90.2.479","article-title":"Juvenile myelomonocytic leukemia","volume":"90","author":"Aric\u00f2","year":"1997","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bneo.2025.100135_bib2","first-page":"3534","article-title":"Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)","volume":"89","author":"Niemeyer","year":"1997","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bneo.2025.100135_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.leu.2402765","article-title":"A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases","volume":"17","author":"Hasle","year":"2003","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bneo.2025.100135_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/(SICI)1096-8652(200004)63:4<212::AID-AJH9>3.0.CO;2-D","article-title":"Myelodysplastic syndromes in children. A critical review of the clinical manifestations and management","volume":"63","author":"Novitzky","year":"2000","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100135_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pcl.2014.09.003","article-title":"Juvenile myelomonocytic leukemia","volume":"62","author":"Satwani","year":"2015","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.bneo.2025.100135_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fped.2014.00025","article-title":"Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantation","volume":"2","author":"Dvorak","year":"2014","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.bneo.2025.100135_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.bneo.2025.100135_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V92.1.267.413a31_267_272","article-title":"Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1","volume":"92","author":"Side","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bneo.2025.100135_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/11631360-000000000-00000","article-title":"Current management of juvenile myelomonocytic leukemia and the impact of RAS mutations","volume":"14","author":"Yoshida","year":"2012","journal-title":"Paediatr Drugs"},{"issue":"12","key":"10.1016\/j.bneo.2025.100135_bib10","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2013-03-491589","article-title":"Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study","volume":"122","author":"Locatelli","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bneo.2025.100135_bib11","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10162","article-title":"Hematopoietic stem cell transplantation-50 years of evolution and future perspectives","volume":"5","author":"Henig","year":"2014","journal-title":"Rambam Maimonides Med J"},{"issue":"3","key":"10.1016\/j.bneo.2025.100135_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2025.100135_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imbio.2015.07.012","article-title":"Tricking the balance: NK cells in anti-cancer immunity","volume":"222","author":"Pahl","year":"2017","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.bneo.2025.100135_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2217\/imt.11.174","article-title":"NK cell therapy: targeting disease relapse after hematopoietic stem cell transplantation","volume":"4","author":"Farhan","year":"2012","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.bneo.2025.100135_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bneo.2025.100135_bib16","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2002-07-2011","article-title":"Successful treatment of juvenile myelomonocytic leukemia relapsing after stem cell transplantation using donor lymphocyte infusion","volume":"101","author":"Worth","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bneo.2025.100135_bib17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/sj.leu.2403721","article-title":"Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia","volume":"19","author":"Yoshimi","year":"2005","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.bneo.2025.100135_bib18","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1182\/blood-2006-04-017566","article-title":"Identification of an immunogenic CD8+ T-cell epitope derived from gamma-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia","volume":"108","author":"Hirano","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bneo.2025.100135_bib19","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.bbmt.2016.04.009","article-title":"Haploidentical natural killer cells infused before allogeneic stem cell transplantation for myeloid malignancies: a phase I trial","volume":"22","author":"Lee","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bneo.2025.100135_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00391","article-title":"Interferon gamma induces changes in natural killer (NK) cell ligand expression and alters NK cell-mediated lysis of pediatric cancer cell lines","volume":"8","author":"Aquino-L\u00f3pez","year":"2017","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.bneo.2025.100135_bib21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ni1580","article-title":"Natural killer cell-directed therapies: moving from unexpected results to successful strategies","volume":"9","author":"Terme","year":"2008","journal-title":"Nat Immunol"},{"issue":"16","key":"10.1016\/j.bneo.2025.100135_bib22","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2017-05-785659","article-title":"Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation [published correction appears in Blood. 2018;132(26):2782]","volume":"130","author":"Ciurea","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2025.100135_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41375-021-01349-4","article-title":"Decrease post-transplant relapse using donor-derived expanded NK-cells","volume":"36","author":"Ciurea","year":"2022","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.bneo.2025.100135_bib24","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/bjh.17751","article-title":"Adoptive immunotherapy with double-bright (CD56(bright)\/CD16(bright)) expanded natural killer cells in patients with relapsed or refractory acute myeloid leukaemia: a proof-of-concept study","volume":"195","author":"Silla","year":"2021","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.bneo.2025.100135_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbmt.2017.10.038","article-title":"Venous thromboembolism in pediatric hematopoietic cell transplant: a multicenter cohort study","volume":"24","author":"Rangarajan","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.bneo.2025.100135_bib26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.molmed.2007.09.003","article-title":"Right on target: eradicating leukemic stem cells","volume":"13","author":"Krause","year":"2007","journal-title":"Trends Mol Med"},{"issue":"12","key":"10.1016\/j.bneo.2025.100135_bib27","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood-2016-10-696039","article-title":"Therapeutic targeting of acute myeloid leukemia stem cells","volume":"129","author":"Pollyea","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bneo.2025.100135_bib28","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3324\/haematol.2009.005967","article-title":"Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells","volume":"94","author":"Langenkamp","year":"2009","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.bneo.2025.100135_bib29","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20180853","article-title":"Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia","volume":"218","author":"Louka","year":"2021","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.bneo.2025.100135_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.smim.2006.03.002","article-title":"Surface NK receptors and their ligands on tumor cells","volume":"18","author":"Moretta","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.bneo.2025.100135_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00601","article-title":"Natural killer cell immunomodulation: targeting activating, inhibitory, and co-stimulatory receptor signaling for cancer immunotherapy","volume":"6","author":"Chester","year":"2015","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.bneo.2025.100135_bib32","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.4049\/jimmunol.177.9.5759","article-title":"The first molecular basis of the \"missing self\" hypothesis","volume":"177","author":"Borrego","year":"2006","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.bneo.2025.100135_bib33","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/jcp.10290","article-title":"MHC class I antigens, immune surveillance, and tumor immune escape","volume":"195","author":"Garcia-Lora","year":"2003","journal-title":"J Cell Physiol"},{"issue":"4","key":"10.1016\/j.bneo.2025.100135_bib34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/pbc.25359","article-title":"Going back to class I: MHC and immunotherapies for childhood cancer","volume":"62","author":"Haworth","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.bneo.2025.100135_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/icb.2010.78","article-title":"Activating and inhibitory receptors of natural killer cells","volume":"89","author":"Pegram","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.bneo.2025.100135_bib36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"10.1016\/j.bneo.2025.100135_bib37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100135_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.cji.0000175686.13368.5c","article-title":"Long-term preservation of antibody-dependent cellular cytotoxicity (ADCC) of natural killer cells amplified in vitro from the peripheral blood of breast cancer patients after chemotherapy","volume":"29","author":"Cl\u00e9menceau","year":"2006","journal-title":"J Immunother"},{"key":"10.1016\/j.bneo.2025.100135_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3389\/fimmu.2013.00481","article-title":"Combination immune therapies to enhance anti-tumor responses by NK cells","volume":"4","author":"Mentlik James","year":"2013","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.bneo.2025.100135_bib40","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2217\/imt.12.38","article-title":"Combination strategies to enhance antitumor ADCC","volume":"4","author":"Kohrt","year":"2012","journal-title":"Immunotherapy"},{"issue":"48","key":"10.1016\/j.bneo.2025.100135_bib41","doi-asserted-by":"crossref","DOI":"10.3791\/2540","article-title":"Expansion, purification, and functional assessment of human peripheral blood NK cells","author":"Somanchi","year":"2011","journal-title":"J Vis Exp"},{"issue":"1","key":"10.1016\/j.bneo.2025.100135_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030264","article-title":"Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells","volume":"7","author":"Denman","year":"2012","journal-title":"PLoS One"},{"issue":"6030","key":"10.1016\/j.bneo.2025.100135_bib43","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.1198704","article-title":"Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum","volume":"332","author":"Bendall","year":"2011","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bneo.2025.100135_bib44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/cyto.a.22271","article-title":"Normalization of mass cytometry data with bead standards","volume":"83","author":"Finck","year":"2013","journal-title":"Cytometry A"},{"issue":"1","key":"10.1016\/j.bneo.2025.100135_bib45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2217\/imt.13.152","article-title":"Immunotherapy in acute myeloid leukemia","volume":"6","author":"Arpinati","year":"2014","journal-title":"Immunotherapy"},{"issue":"5562","key":"10.1016\/j.bneo.2025.100135_bib46","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bneo.2025.100135_bib47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2011.12.017","article-title":"Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity","volume":"318","author":"She","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bneo.2025.100135_bib48","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3389\/fimmu.2017.01330","article-title":"The more, the better: \"do the right thing\" for natural killer immunotherapy in acute myeloid leukemia","volume":"8","author":"Parisi","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.bneo.2025.100135_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00479","article-title":"Alloreactive natural killer cells for the treatment of acute myeloid leukemia: from stem cell transplantation to adoptive immunotherapy","volume":"6","author":"Ruggeri","year":"2015","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.bneo.2025.100135_bib50","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1158\/1078-0432.CCR-15-3168","article-title":"Natural killer cell-based immunotherapy in acute myeloid leukemia: lessons for the future","volume":"22","author":"Muntasell","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.bneo.2025.100135_bib51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2249.2009.03983.x","article-title":"Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias","volume":"157","author":"Moretta","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"7768","key":"10.1016\/j.bneo.2025.100135_bib52","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-1410-1","article-title":"Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion","volume":"572","author":"Paczulla","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bneo.2025.100135_bib53","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4252\/wjsc.v6.i4.473","article-title":"Identification and targeting leukemia stem cells: the path to the cure for acute myeloid leukemia","volume":"6","author":"Zhou","year":"2014","journal-title":"World J Stem Cells"},{"issue":"3","key":"10.1016\/j.bneo.2025.100135_bib54","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.seminhematol.2015.03.008","article-title":"Biology and clinical relevance of acute myeloid leukemia stem cells","volume":"52","author":"Reinisch","year":"2015","journal-title":"Semin Hematol"},{"issue":"9","key":"10.1016\/j.bneo.2025.100135_bib55","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/onc.2010.511","article-title":"Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells","volume":"30","author":"Majeti","year":"2011","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bneo.2025.100135_bib56","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2141.2010.08300.x","article-title":"A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting","volume":"150","author":"K\u00fcgler","year":"2010","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.bneo.2025.100135_bib57","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2141.2009.08033.x","article-title":"Novel conjugates of single-chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells","volume":"148","author":"Stein","year":"2010","journal-title":"Br J Haematol"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025000706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025000706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:57:27Z","timestamp":1777640247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328025000706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2950328025000706"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100135","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile myelomonocytic leukemia stem cells are sensitive to NK cell\u2013mediated lysis and express targetable antigens","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100135"}}